None listed
Conditions
Interventions
Drug : Patients will be pretreated with aspirin 100 mg and clopidogrel 75 mg before 1 week from elective PCI. If not, aspirin 300 mg and clopidogrel 300-600 mg will be loaded before elective PCI. PCI
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subject must be at least 20 years of age. (2) Patients undergoing percutaneous coronary intervention with drug-eluting stents (3) Signed written informed consent
Exclusion criteria
Exclusion criteria: (1) known hypersensibility to aspirin, prasugrel, clopidogrel, ticagrelor, everolimus, sirolimus, contrast medium (2) Active bleeding (3) Cardiogenic shock (4) Pregnant or breast-feeding women or Female of childbearing potential, who possibly plan to become pregnant any time after enrollment into this study (5) Non-cardiac co-morbid conditions are present with life expectancy <2 year or that may result in protocol non-compliance (per site investigator's medical judgment). (6) DES implantation within 12 months before index procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A composite of death, myocardial infarction, or cerebrovascular events | — |
Secondary
| Measure | Time frame |
|---|---|
| All death, cardiac death, Myocardial infarction (MI), Cerebrovascular accident (CVA), Target lesion revascularization (TLR), Target vessel revascularization (TVR), Any revascularization, Stent thrombosis: definite or probable stent thrombosis by ARC definition, BARC bleeding =2, BARC bleeding =3, Major adverse cardiocerebral event (MACCE): death, MI, CVA, or any revascularization | — |
Countries
Korea, Republic of
Contacts
Public ContactHyeonCheol Kwon
Samsung Medical Center
Outcome results
None listed